mirtazapine has been researched along with Hypernatremia in 1 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Hypernatremia: Excessive amount of sodium in the blood. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Psychogenic adipsic hypernatremia is an exceedingly rare and life-threatening condition, occurring in those with severe psychiatric disorders." | 1.51 | Hypernatremic Hydrophobic Transient Adipsia Without Organic or Severe Psychiatric Disorder. ( Fogelfeld, L; Robertson, G; Rodriguez, A, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rodriguez, A | 1 |
| Fogelfeld, L | 1 |
| Robertson, G | 1 |
1 other study available for mirtazapine and Hypernatremia
| Article | Year |
|---|---|
Hypernatremic Hydrophobic Transient Adipsia Without Organic or Severe Psychiatric Disorder.
Topics: Antidepressive Agents; Depressive Disorder; Female; Humans; Hypernatremia; Middle Aged; Mirtazapine; | 2019 |